Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Myelofibrosis
Closed
Phase 1
This trial is adding PLX2853 to ruxolitinib. It is for people with myelofibrosis who are already taking ruxolitinib but it isn’t working too well for them.
Cancer Research UK supports this trial.
Recruitment start: 28 April 2021
Recruitment end: 30 June 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Adam Mead
Cancer Research UK
University of Birmingham
This is Cancer Research UK trial number CRUK/18/008.
Last reviewed: 29 June 2025
CRUK internal database number: 16447
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
